| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.073 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |